Endocrine Complications of COVID-19: Short and Long

Kamyar Asadipooya^*

• University of Kentucky, Lexington, United States

mechanism by which SARS-CoV-2 damages human tissues, including the endocrine structures. Furthermore, heightened inflammatory responses and cytokine production following acute SARS-CoV-2 infection could be responsible for multiple organ injuries and potential endocrine system dysfunction (1). However, the immune response following exposure to SARS-CoV-2 antigens are not always associated with endocrine organ dysfunction. For instance, immune response following vaccination was not significantly associated with endocrine system damage, including human reproductive system (Bao et Generally, management of acute SARS-CoV-2 infection is not limited to controlling viral replication and inflammation. We must consider the possible complications during acute infection or after recovery. The current therapeutic recommendation is mainly antivirals.However, this approach is probably facing a barrier, which is caused by the mutated forms of SARS-CoV-2. These mutations ultimately increase the transmission rate, escape the immune response following vaccination and endorse resistance to antiviral medications. Targeting ACE2 or other SARS-CoV-2 receptors may be a helpful strategy in reducing virus entry into host cells and mitigating severity of illness. Blocking virus interaction with its receptors or tackling receptors will bypass this defense mechanisms of SARS-CoV-2 mutated forms. This could be achieved by (1) reducing the interaction between ACE2 on cell membrane and SARS-CoV-2 spike protein, (2) reducing the amount of soluble ACE2 or dipeptidyl peptidase 4 (DPP-4), which leads to less viral engulfment, (3) capturing SARS-CoV-2 with a decoy receptor before entering into the cells, and (4) manipulating the expression or function of ACE2 genetically or with medications. However, ACE2 on cell membrane has protective roles and the fourth approach could be potentially harmful (12,13).In summary, providing more evidence about the complications and treatments of COVID-19 is necessary. Based on the possible complications, including long COVID, endocrine disruption etc., managing COVID-19 is not restricted to the treatment of acute SARS-CoV-2 infection and healthcare providers need to investigate the complications appropriately.